Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mojgan Reza

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Human Gene Therapy Methods|August 2, 2016
Optimization of Internally Deleted Dystrophin ConstructsMojgan Reza, Steve H Laval, Andreas Roos, et al.
Scientific Reports|January 28, 2016
Autologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular DystrophyJinhong Meng, John R Counsell, Mojgan Reza, et al.
Stem Cell Research|November 25, 2010
Two new protocols to enhance the production and isolation of human induced pluripotent stem cell linesEmily Dick, Elena Matsa, Jayson Bispham, et al.
Neuromuscular Disorders : NMD|September 3, 2017
MRC Centre Neuromuscular Biobank (Newcastle and London): Supporting and facilitating rare and neuromuscular disease research worldwideMojgan Reza, Daniel Cox, Lauren Phillips, et al.
Human Molecular Genetics|July 13, 2013
Mitochondrial DNA deletions in muscle satellite cells: implications for therapiesSally Spendiff, Mojgan Reza, Julie L Murphy, et al.
Blood Advances|October 12, 2021
GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1Preeti Singh, Maninder Heer, Anastasia Resteu, et al.
Biochimica Et Biophysica Acta|October 29, 2013
Mutation of the human mitochondrial phenylalanine-tRNA synthetase causes infantile-onset epilepsy and cytochrome c oxidase deficiencyAbdulraheem Almalki, Charlotte L Alston, Alasdair Parker, et al.
Journal of Neuromuscular Diseases|May 12, 2020
Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophyKristin Strandberg, Burcu Ayoglu, Andreas Roos, et al.
Nature Communications|January 23, 2021
RUNX1/RUNX1T1 mediates alternative splicing and reorganises the transcriptional landscape in leukemiaVasily V Grinev, Farnaz Barneh, Ilya M Ilyushonak, et al.
European Journal of Human Genetics : EJHG|January 4, 2020
TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophyPietro Spitali, Irina Zaharieva, Stefan Bohringer, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Human Gene Therapy Methods|August 2, 2016
Optimization of Internally Deleted Dystrophin ConstructsMojgan Reza, Steve H Laval, Andreas Roos, et al.
Scientific Reports|January 28, 2016
Autologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular DystrophyJinhong Meng, John R Counsell, Mojgan Reza, et al.
Stem Cell Research|November 25, 2010
Two new protocols to enhance the production and isolation of human induced pluripotent stem cell linesEmily Dick, Elena Matsa, Jayson Bispham, et al.
Neuromuscular Disorders : NMD|September 3, 2017
MRC Centre Neuromuscular Biobank (Newcastle and London): Supporting and facilitating rare and neuromuscular disease research worldwideMojgan Reza, Daniel Cox, Lauren Phillips, et al.
Human Molecular Genetics|July 13, 2013
Mitochondrial DNA deletions in muscle satellite cells: implications for therapiesSally Spendiff, Mojgan Reza, Julie L Murphy, et al.
Blood Advances|October 12, 2021
GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1Preeti Singh, Maninder Heer, Anastasia Resteu, et al.
Biochimica Et Biophysica Acta|October 29, 2013
Mutation of the human mitochondrial phenylalanine-tRNA synthetase causes infantile-onset epilepsy and cytochrome c oxidase deficiencyAbdulraheem Almalki, Charlotte L Alston, Alasdair Parker, et al.
Journal of Neuromuscular Diseases|May 12, 2020
Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophyKristin Strandberg, Burcu Ayoglu, Andreas Roos, et al.
Nature Communications|January 23, 2021
RUNX1/RUNX1T1 mediates alternative splicing and reorganises the transcriptional landscape in leukemiaVasily V Grinev, Farnaz Barneh, Ilya M Ilyushonak, et al.
European Journal of Human Genetics : EJHG|January 4, 2020
TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophyPietro Spitali, Irina Zaharieva, Stefan Bohringer, et al.
Pageof 2